Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis

4Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

COVID-19 vaccines are safe for people living with MS on or off disease-modifying therapies and are important for the prevention of COVID-19. Antibody responses for individuals on certain DMTs may be diminished, however, T-cell responses may be preserved in those individuals. Data are lacking regarding optimal timing of vaccinations, and delaying disease-modifying therapies may increase the risk of disease activity and progression. In this perspective podcast, the authors recommend COVID-19 vaccination as soon as possible, regardless of timing considerations, in most cases. Graphical Plain Language Summary: [Figure not available: see fulltext.]

Cite

CITATION STYLE

APA

Shin, R. K., Rammohan, K. W., & Williams, M. J. (2021, December 1). Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis. Neurology and Therapy. Adis. https://doi.org/10.1007/s40120-021-00266-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free